Debt-to-equity of IGC Pharma, Inc. from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IGC Pharma, Inc. quarterly Debt-to-equity in % history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • IGC Pharma, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 33%, a 1.4% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 33% 0% -1.4% 30 Sep 2025
Q2 2025 39% +13% +50% 30 Jun 2025
Q1 2025 39% +17% +78% 31 Mar 2025
Q4 2024 39% +20% +111% 31 Dec 2024
Q3 2024 33% +18% +126% 30 Sep 2024
Q2 2024 26% +13% +107% 30 Jun 2024
Q1 2024 22% +12% +110% 31 Mar 2024
Q4 2023 18% +8% +78% 31 Dec 2023
Q3 2023 15% +6% +62% 30 Sep 2023
Q2 2023 12% +4% +41% 30 Jun 2023
Q1 2023 11% +2% +22% 31 Mar 2023
Q4 2022 10% +2% +26% 31 Dec 2022
Q3 2022 9% 0% -3.4% 30 Sep 2022
Q2 2022 9% -1% -13% 30 Jun 2022
Q1 2022 9% -3% -26% 31 Mar 2022
Q4 2021 8% -4% -31% 31 Dec 2021
Q3 2021 9% 0% -0.84% 30 Sep 2021
Q2 2021 10% +2% +30% 30 Jun 2021
Q1 2021 12% +6% +115% 31 Mar 2021
Q4 2020 12% +8% +202% 31 Dec 2020
Q3 2020 9% +6% +201% 30 Sep 2020
Q2 2020 8% +3% +72% 30 Jun 2020
Q1 2020 5% -4% -39% 31 Mar 2020
Q4 2019 4% -11% -74% 31 Dec 2019
Q3 2019 3% -33% -91% 30 Sep 2019
Q2 2019 5% -44% -91% 30 Jun 2019
Q1 2019 9% -40% -82% 31 Mar 2019
Q4 2018 15% -40% -72% 31 Dec 2018
Q3 2018 36% -18% -33% 30 Sep 2018
Q2 2018 49% +7% +16% 30 Jun 2018
Q1 2018 49% +10% +27% 31 Mar 2018
Q4 2017 55% +19% +52% 31 Dec 2017
Q3 2017 54% +19% +57% 30 Sep 2017
Q2 2017 42% +6% +16% 30 Jun 2017
Q1 2017 39% +1% +3% 31 Mar 2017
Q4 2016 36% -2% -6.4% 31 Dec 2016
Q3 2016 34% -3% -7.3% 30 Sep 2016
Q2 2016 36% -1% -1.7% 30 Jun 2016
Q1 2016 38% +4% +13% 31 Mar 2016
Q4 2015 38% +8% +26% 31 Dec 2015
Q3 2015 37% +7% +25% 30 Sep 2015
Q2 2015 37% +8% +30% 30 Jun 2015
Q1 2015 33% +5% +18% 31 Mar 2015
Q4 2014 31% +1% +4.4% 31 Dec 2014
Q3 2014 30% -2% -7.3% 30 Sep 2014
Q2 2014 28% -12% -30% 30 Jun 2014
Q1 2014 28% -21% -43% 31 Mar 2014
Q4 2013 29% -29% -50% 31 Dec 2013
Q3 2013 32% -49% -60% 30 Sep 2013
Q2 2013 41% -50% -55% 30 Jun 2013
Q1 2013 49% -52% -51% 31 Mar 2013
Q4 2012 58% -63% -52% 31 Dec 2012
Q3 2012 81% 30 Sep 2012
Q2 2012 91% 30 Jun 2012
Q1 2012 101% 31 Mar 2012
Q4 2011 121% 31 Dec 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.